Search Results

There are 6029 results for: content related to: Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas

  1. You have free access to this content
    Temozolomide for high grade glioma

    Intervention Review

    The Cochrane Library

    Michael G Hart, Ruth Garside, Gabriel Rogers, Ken Stein and Robin Grant

    Published Online : 30 APR 2013, DOI: 10.1002/14651858.CD007415.pub2

  2. You have free access to this content
    MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis

    STEM CELLS

    Volume 29, Issue 12, December 2011, Pages: 1942–1951, Atsushi Sato, Jun Sunayama, Ken-ichiro Matsuda, Shizuka Seino, Kaori Suzuki, Eriko Watanabe, Ken Tachibana, Arata Tomiyama, Takamasa Kayama and Chifumi Kitanaka

    Version of Record online : 16 NOV 2011, DOI: 10.1002/stem.753

  3. You have free access to this content
    Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment

    Clinical Endocrinology

    Volume 76, Issue 6, June 2012, Pages: 769–775, Gérald Raverot, Frédéric Castinetti, Emmanuel Jouanneau, Isabelle Morange, Dominique Figarella-Branger, Henry Dufour, Jacqueline Trouillas and Thierry Brue

    Version of Record online : 23 APR 2012, DOI: 10.1111/j.1365-2265.2012.04381.x

  4. Temozolomide in Patients with Advanced Cancer: Phase I and Pharmacokinetic Study

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 1, January 2004, Pages: 16–25, Dr. Michelle A. Rudek, Dr. Ross C. Donehower, Dr. Paul Statkevich, Dr. Vijay K. Batra, Dr. David L. Cutler and Dr. Sharyn D. Baker

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.1.16.34800

  5. Crystal Engineering of Stable Temozolomide Cocrystals

    Chemistry – An Asian Journal

    Volume 7, Issue 10, October 2012, Pages: 2274–2285, Dr. N. Jagadeesh Babu, Palash Sanphui and Prof. Ashwini Nangia

    Version of Record online : 21 MAY 2012, DOI: 10.1002/asia.201200205

  6. You have free access to this content
    Bevacizumab and daily temozolomide for recurrent glioblastoma

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1302–1312, Annick Desjardins, David A. Reardon, April Coan, Jennifer Marcello, James E. Herndon II, Leighann Bailey, Katherine B. Peters, Henry S. Friedman and James J. Vredenburgh

    Version of Record online : 26 JUL 2011, DOI: 10.1002/cncr.26381

  7. Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1

    Experimental Dermatology

    Volume 26, Issue 7, July 2017, Pages: 598–606, Heike Niessner, Corinna Kosnopfel, Tobias Sinnberg, Daniela Beck, Kathrin Krieg, Ines Wanke, Konstantinos Lasithiotakis, Michael Bonin, Claus Garbe and Friedegund Meier

    Version of Record online : 12 JUL 2017, DOI: 10.1111/exd.13372

  8. You have free access to this content
    Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme

    Cancer

    Volume 116, Issue 15, 1 August 2010, Pages: 3663–3669, John D. Hainsworth, Thomas Ervin, Elke Friedman, Victor Priego, Patrick B. Murphy, Bobby L. Clark and Ruth E. Lamar

    Version of Record online : 11 MAY 2010, DOI: 10.1002/cncr.25275

  9. Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program

    Pediatric Blood & Cancer

    Volume 60, Issue 5, May 2013, Pages: 783–790, Stephen T. Keir, John M. Maris, C. Patrick Reynolds, Min H. Kang, E. Anders Kolb, Richard Gorlick, Richard Lock, Hernan Carol, Christopher L. Morton, Jianrong Wu, Raushan T. Kurmasheva, Peter J. Houghton and Malcolm A. Smith

    Version of Record online : 17 JAN 2013, DOI: 10.1002/pbc.24368

  10. You have free access to this content
    First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas

    Cancer

    Volume 117, Issue 2, 15 January 2011, Pages: 268–275, Jonathan R. Strosberg, Robert L. Fine, Junsung Choi, Aejaz Nasir, Domenico Coppola, Dung-Tsa Chen, James Helm and Larry Kvols

    Version of Record online : 7 SEP 2010, DOI: 10.1002/cncr.25425

  11. Temozolomide

    Cancer Practice

    Volume 8, Issue 6, November/December 2000, Pages: 311–313, Julie Schwenka and Robert J. Ignoffo

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1523-5394.2000.86004.pp.x

  12. You have free access to this content
    Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status

    European Journal of Clinical Investigation

    Volume 41, Issue 10, October 2011, Pages: 1133–1148, Ann I. McCormack, John A. H. Wass and Ashley B. Grossman

    Version of Record online : 18 APR 2011, DOI: 10.1111/j.1365-2362.2011.02520.x

  13. You have free access to this content
    Treatment of pituitary neoplasms with temozolomide

    Cancer

    Volume 117, Issue 3, 1 February 2011, Pages: 454–462, Luis V. Syro, Leon D. Ortiz, Bernd W. Scheithauer, Ricardo Lloyd, Queenie Lau, Ricardo Gonzalez, Humberto Uribe, Michael Cusimano, Kalman Kovacs and Eva Horvath

    Version of Record online : 15 SEP 2010, DOI: 10.1002/cncr.25413

  14. You have free access to this content
    Dose-dense temozolomide regimens

    Cancer

    Volume 116, Issue 12, 15 June 2010, Pages: 2868–2877, Bart Neyns, Alicia Tosoni, Wen-Jen Hwu and David A. Reardon

    Version of Record online : 29 MAR 2010, DOI: 10.1002/cncr.25035

  15. You have free access to this content
    RIST: A potent new combination therapy for glioblastoma

    International Journal of Cancer

    Volume 136, Issue 4, 15 February, 2015, Pages: E173–E187, Lisa Nonnenmacher, Mike-Andrew Westhoff, Simone Fulda, Georg Karpel-Massler, Marc-Eric Halatsch, Jens Engelke, Thomas Simmet, Selim Corbacioglu and Klaus-Michael Debatin

    Version of Record online : 1 SEP 2014, DOI: 10.1002/ijc.29138

  16. You have free access to this content
    Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme

    Cancer

    Volume 121, Issue 17, September 1, 2015, Pages: 2926–2932, Young-Hoon Kim, Tackeun Kim, Jin-Deok Joo, Jung Ho Han, Yu Jung Kim, In Ah Kim, Chang-Ho Yun and Chae-Yong Kim

    Version of Record online : 14 MAY 2015, DOI: 10.1002/cncr.29439

  17. You have free access to this content
    A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor

    Cancer

    Volume 119, Issue 17, 1 September 2013, Pages: 3212–3218, Jennifer A. Chan, Lawrence Blaszkowsky, Keith Stuart, Andrew X. Zhu, Jill Allen, Raymond Wadlow, David P. Ryan, Jeffrey Meyerhardt, Marielle Gonzalez, Eileen Regan, Hui Zheng and Matthew H. Kulke

    Version of Record online : 3 JUN 2013, DOI: 10.1002/cncr.28142

  18. Synthesis of [3-N-11C-methyl]temozolomide via in situ activation of 3-N-hydroxymethyl temozolomide and alkylation with [11C]methyl iodide

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 58, Issue 3, March 2015, Pages: 122–126, Jonas Eriksson, Rolph Van Kooij, Robert C. Schuit, Femke E. Froklage, Jaap C. Reijneveld, N. Harry Hendrikse and Albert D. Windhorst

    Version of Record online : 17 FEB 2015, DOI: 10.1002/jlcr.3251

  19. You have free access to this content
    Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508

    Cancer

    Volume 116, Issue 2, 15 January 2010, Pages: 424–431, Joseph I. Clark, James Moon, Laura F. Hutchins, Jeffrey A. Sosman, W. Martin Kast, Diane M. Da Silva, P. Y. Liu, John A. Thompson, Lawrence E. Flaherty and Vernon K. Sondak

    Version of Record online : 13 NOV 2009, DOI: 10.1002/cncr.24739

  20. You have free access to this content
    Cytotoxic chemotherapy for pancreatic neuroendocrine tumors

    Journal of Hepato-Biliary-Pancreatic Sciences

    Volume 22, Issue 8, August 2015, Pages: 628–633, Takuji Okusaka, Hideki Ueno, Chigusa Morizane, Shunsuke Kondo, Yasunari Sakamoto, Hideaki Takahashi, Izumi Ohno, Satoshi Shimizu, Shuichi Mitsunaga and Masafumi Ikeda

    Version of Record online : 3 MAY 2015, DOI: 10.1002/jhbp.257